Anuncio
Anuncio

MGX

MGX logo

Metagenomi Therapeutics, Inc. Common Stock

1.20
USD
Patrocinado
-0.05
-4.00%
12 jun, 15:57 UTC -4
Cerrado
exchange

Pre-mercado

1.26

+0.06
+5.33%

Panorámica financiera de Metagenomi Therapeutics, Inc. Common Stock

Cap. de Mercado
47.59M
Beta
0.56
Beneficios Por Acción (BPA)
-2.37
Ratio Precio/Valor (P/V) Contable
0.33
Margen de explotación
-348.54%
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
--
Rentabilidad sobre recursos propios (ROE)
-47.14%
Ratio de liquidez
7.22%
Flujo de caja libre
-89.43M
Perfil de MGX

Gráfico de Beneficios

Beneficios de MGX

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$981.61
-1.43%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$160.95
+632.26%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1980.10
+5.24%
Nvidia Corp logo
Nvidia Corp$205.19
+0.16%
Intel Corp logo
Intel Corp$124.57
+6.51%
Marvell Technology, Inc. Common Stock logo
Marvell Technology, Inc. Common Stock$279.70
-0.36%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$406.43
+1.82%
Anuncio